Results 221 to 230 of about 113,823 (359)

Balancing Promise and Peril: Hemophilia Gene Therapy Insights. [PDF]

open access: yesIUBMB Life
Akula S   +4 more
europepmc   +1 more source

Real‐World Effectiveness and Safety of Damoctocog Alfa Pegol in Severe and Nonsevere Patients With Hemophilia A From the Prospective, Multinational, Ongoing HEM‐POWR Study

open access: yesEuropean Journal of Haematology, Volume 116, Issue 2, Page 148-159, February 2026.
ABSTRACT Objectives To assess the effectiveness and safety of damoctocog alfa pegol in patients with severe and nonsevere hemophilia A in the fifth interim analysis of the ongoing HEM‐POWR study. Methods HEM‐POWR (NCT03932201) is a multinational, Phase 4, prospective observational study.
Mark T. Reding   +7 more
wiley   +1 more source

PB2654: RARE BLEEDING DISORDERS: LONG-TERM EXPERIENCE FROM A HEMOPHILIA CENTER

open access: yesHemaSphere, 2023
Antonios Meimaridis   +5 more
doaj   +1 more source

Acquired Hemophilia

open access: yesInternal Medicine, 2015
Kenji, Kimura   +3 more
openaire   +3 more sources

Health care resources and costs associated with delivering gene therapy for hemophilia in clinical practice. [PDF]

open access: yesRes Pract Thromb Haemost
Prameyllawati DM   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy